ConductScience.org, home

Paper29237828

Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.

Qualls ZM and 5 others. J Virol, 2018. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates. Papers, record 29237828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29237828

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.
PubMed
Journal
J Virol
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2018-11-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qualls ZMZakiya M
2Choudhary AAlok
3Honnen WWilliam
4Prattipati RRaja
5Robinson JEJames E
6Pinter AAbraham

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, NeutralizingMajor topic
Genes, envMajor topic
HIV AntibodiesMajor topic
HIV-1Major topic
env Gene Products, Human Immunodeficiency VirusMajor topic
Amino Acid Sequence
Drug Substitution
Epitopes
HEK293 Cells
HIV Envelope Protein gp120
HIV Envelope Protein gp160
HIV Envelope Protein gp41
HIV Infections
Humans
In Vitro Techniques
Mutation
Neutralization Tests
Phenotype
Protein Conformation

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 AI088610NIAID NIH HHSUnited StatesP01AI088610PubMed and NIHNIH RePORTER
R01 AI102718NIAID NIH HHSUnited StatesR01AI102718PubMed and NIHNIH RePORTER

Download CSV of grants

References103

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115795308Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles.J Virol2005https://conductscience.org/library/papers/15795308PubMed
29371651Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein.J Virol1997https://conductscience.org/library/papers/9371651PubMed
323540694Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization.Cell2013https://conductscience.org/library/papers/23540694PubMed
425965315A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site.Mol Immunol2015https://conductscience.org/library/papers/25965315PubMed
524068931A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.PLoS Pathog2013https://conductscience.org/library/papers/24068931PubMed
612487827Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies.AIDS Res Hum Retroviruses2002https://conductscience.org/library/papers/12487827PubMed
719965434Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.Science2009https://conductscience.org/library/papers/19965434PubMed
821270156Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop.J Virol2011https://conductscience.org/library/papers/21270156PubMed
912646921Antibody neutralization and escape by HIV-1.Nature2003https://conductscience.org/library/papers/12646921PubMed
1010623724
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
J Virol2000https://conductscience.org/library/papers/10623724PubMed
1118653472Only five of 10 strictly conserved disulfide bonds are essential for folding and eight for function of the HIV-1 envelope glycoprotein.Mol Biol Cell2008https://conductscience.org/library/papers/18653472PubMed
1217121806
Type-specific epitopes targeted by monoclonal antibodies with exceptionally potent neutralizing activities for selected strains of human immunodeficiency virus type 1 map to a common region of the V2 domain of gp120 and differ only at single positions from the clade B consensus sequence.
J Virol2007https://conductscience.org/library/papers/17121806PubMed
1323086475Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape.Nat Med2012https://conductscience.org/library/papers/23086475PubMed
147543586Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.J Virol1995https://conductscience.org/library/papers/7543586PubMed
1520538861Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1.J Virol2010https://conductscience.org/library/papers/20538861PubMed
1618057243The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection.J Virol2008https://conductscience.org/library/papers/18057243PubMed
1710888615
V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
J Virol2000https://conductscience.org/library/papers/10888615PubMed
187533854Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain.J Virol1995https://conductscience.org/library/papers/7533854PubMed
1920616233Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.Science2010https://conductscience.org/library/papers/20616233PubMed
2017721546Broad HIV-1 neutralization mediated by CD4-binding site antibodies.Nat Med2007https://conductscience.org/library/papers/17721546PubMed

See all 103 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42065725HIV-1 and Vaccine: Analysis of gp41 Target Sequences.Curr Microbiol2026https://conductscience.org/library/papers/42065725PubMed
37854587Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1.Front Immunol2023https://conductscience.org/library/papers/37854587PubMed
37681958Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells.J Virol2023https://conductscience.org/library/papers/37681958PubMed
35372102Neutralization Sensitivity of HIV-1 CRF07_BC From an Untreated Patient With a Focus on Evolution Over Time.Front Cell Infect Microbiol2022https://conductscience.org/library/papers/35372102PubMed
35228534High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers.NPJ Vaccines2022https://conductscience.org/library/papers/35228534PubMed
31827000Impact of Th1 CD4 Follicular Helper T Cell Skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus Macaques.J Virol2020https://conductscience.org/library/papers/31827000PubMed
31523362Antiretroviral drug-S for a possible HIV elimination.Int J Physiol Pathophysiol Pharmacol2019https://conductscience.org/library/papers/31523362PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
ERVK-20100616444PubTator's text mininghttps://conductscience.org/library/genes/100616444NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29237828

GET https://conductscience.org/api/papers/v1/29237828/references?page=2